© 1996 British Society for Rheumatology
research-article |
NATURAL REMISSION IN INFLAMMATORY POLYARTHRITIS: ISSUES OF DEFINITION AND PREDICTION
ARC Epidemiology Research Unit Stopford Building, Oxford Road, Manchester M13 9PT
*Norfolk Arthritis Register, St Michael's Hospital Aylsham, Norfolk NR11 6NA
This paper reports the frequency and predictors of remission (no arthritis on examination and no treatment with second-line drugs or steroids within the previous 3 months) in 358 patients with early inflammatory polyarthritis (IP) referred to the Norfolk Arthritis Register. Two years after referral, 91 patients (25%) were in remission, 32 of whom had also been in remission at 1 yr. Remission rates were twice as high in patients with undifferentiated inflammatory polyarthritis at baseline as in those who satisfied criteria for rheumatoid arthritis. To identify predictors of remission, a logistic regression model was developed on a random two-thirds of the patients and validated on the remaining one-third. Remission at 2 yr was associated with male gender and fewer than six tender joints at baseline. However, even the best-fitting model was not sensitive enough to be useful clinically. Thus, amongst patients with early IP in the community, remission rates at 2 yr are low. Further, it was impossible, using simple clinical measures, to predict those patients whose arthritis would resolve.
KEY WORDS: Arthritis, Inflammatory polyarthritis, Rheumatoid arthritis, Remission
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  B Kuriya, C K Cheng, H M Chen, and V P Bykerk Validation of a prediction rule for development of rheumatoid arthritis in patients with early undifferentiated arthritis Ann Rheum Dis, September 1, 2009; 68(9): 1482 - 1485. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Cantini, L. Niccoli, C. Nannini, E. Cassara, P. Pasquetti, I. Olivieri, and C. Salvarani Frequency and duration of clinical remission in patients with peripheral psoriatic arthritis requiring second-line drugs Rheumatology, June 1, 2008; 47(6): 872 - 876. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Bukhari, A. N. Bamji, and C. Deighton Is it ever appropriate to discharge patients with rheumatoid arthritis? Rheumatology, November 1, 2007; 46(11): 1631 - 1633. [Full Text] [PDF]
|
|
|
|
|
|
H Makinen, H Kautiainen, P Hannonen, and T Sokka Is DAS28 an appropriate tool to assess remission in rheumatoid arthritis? Ann Rheum Dis, October 1, 2005; 64(10): 1410 - 1413. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Yarilin, J. Valiando, and D. N. Posnett A Mouse Herpesvirus Induces Relapse of Experimental Autoimmune Arthritis by Infection of the Inflammatory Target Tissue J. Immunol., October 15, 2004; 173(8): 5238 - 5246. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E Suresh Diagnosis of early rheumatoid arthritis: what the non-specialist needs to know J R Soc Med, September 1, 2004; 97(9): 421 - 424. [Full Text] [PDF]
|
|
|
|
|
|
L Gossec, M Dougados, P Goupille, A Cantagrel, J Sibilia, O Meyer, J Sany, J-P Daures, and B Combe Prognostic factors for remission in early rheumatoid arthritis: a multiparameter prospective study Ann Rheum Dis, June 1, 2004; 63(6): 675 - 680. [Abstract] [Full Text]
|
|
|
|
|
|
J S Smolen and D Aletaha Patients with rheumatoid arthritis in clinical care Ann Rheum Dis, March 1, 2004; 63(3): 221 - 225. [Full Text] [PDF]
|
|
|
|
|
|
P Emery, F C Breedveld, M Dougados, J R Kalden, M H Schiff, and J S Smolen Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide Ann Rheum Dis, April 1, 2002; 61(4): 290 - 297. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Quinn, P. G. Conaghan, and P. Emery The therapeutic approach of early intervention for rheumatoid arthritis: what is the evidence? Rheumatology, November 1, 2001; 40(11): 1211 - 1220. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Visser, I. Speyer, B. Ozcan, F. C. Breedveld, M. L. van Ogtrop, and J. M. W. Hazes The diagnostic value of streptococcal serology in early arthritis: a prospective cohort study Rheumatology, December 1, 2000; 39(12): 1351 - 1356. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Harrison and D. Symmons Early inflammatory polyarthritis: results from the Norfolk Arthritis Register with a review of the literature. II. Outcome at three years Rheumatology, September 1, 2000; 39(9): 939 - 949. [Full Text] [PDF]
|
|
|
|
|
|
B. Svensson, C. Schaufelberger, A. Teleman, and J. Theander Remission and response to early treatment of RA assessed by the Disease Activity Score Rheumatology, September 1, 2000; 39(9): 1031 - 1036. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Smolen, W. B. Graninger, and P. Emery Leflunomide, a new disease-modifying anti-rheumatic drug and the never ending rheumatoid arthritis story Rheumatology, July 1, 2000; 39(7): 689 - 692. [Full Text] [PDF]
|
|
|
|
|
|
E. T. H. Molenaar, W. F. Lems, B. A. C. Dijkmans, M. H. M. T. de Koning, R. J. van de Stadt, and A. E. Voskuyl Levels of markers of bone resorption are moderately increased in patients with inactive rheumatoid arthritis Rheumatology, July 1, 2000; 39(7): 742 - 744. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C H M van Jaarsveld, J W G Jacobs, M J van der Veen, A A M Blaauw, A A Kruize, D M Hofman, H L M Brus, G A van Albada-Kuipers, A H M Heurkens, E J ter Borg, et al. Aggressive treatment in early rheumatoid arthritis: a randomised controlled trial Ann Rheum Dis, June 1, 2000; 59(6): 468 - 477. [Abstract] [Full Text]
|
|
|
|
|
|
B. J. Harrison, A. J. Silman, D. P. M. Symmons, C. T. Pease, B. Bhakta, J. Devlin, and P. Emery Does the age of onset of rheumatoid arthritis influence phenotype?: a prospective study of outcome and prognostic factors Rheumatology, January 1, 2000; 39(1): 112 - 113. [Full Text] [PDF]
|
|
|
|
|
|
L B A VAN DE PUTTE, A M VAN GESTEL, and P L C M VAN RIEL Early treatment of rheumatoid arthritis: rationale, evidence, and implications Ann Rheum Dis, September 1, 1998; 57(9): 511 - 512. [Full Text]
|
|